Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Factors affecting duration of chronic fatigue syndrome in pediatric patients.

Petrov D, Marchalik D, Sosin M, Bal A.

Indian J Pediatr. 2012 Jan;79(1):52-5. doi: 10.1007/s12098-011-0463-4. Epub 2011 May 27.

PMID:
21617905
2.

Diagnostic evaluation of 2', 5'-oligoadenylate synthetase activities and antibodies against Epstein-Barr virus and Coxiella burnetii in patients with chronic fatigue syndrome in Japan.

Ikuta K, Yamada T, Shimomura T, Kuratsune H, Kawahara R, Ikawa S, Ohnishi E, Sokawa Y, Fukushi H, Hirai K, Watanabe Y, Kurata T, Kitani T, Sairenji T.

Microbes Infect. 2003 Oct;5(12):1096-102.

PMID:
14554250
3.

Serologic and virologic epidemiology of Epstein-Barr virus: relevance to chronic fatigue syndrome.

Sumaya CV.

Rev Infect Dis. 1991 Jan-Feb;13 Suppl 1:S19-25. Review.

PMID:
1850540
4.

Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.

Loebel M, Eckey M, Sotzny F, Hahn E, Bauer S, Grabowski P, Zerweck J, Holenya P, Hanitsch LG, Wittke K, Borchmann P, Rüffer JU, Hiepe F, Ruprecht K, Behrends U, Meindl C, Volk HD, Reimer U, Scheibenbogen C.

PLoS One. 2017 Jun 12;12(6):e0179124. doi: 10.1371/journal.pone.0179124. eCollection 2017.

5.

A six-month trial of valacyclovir in the Epstein-Barr virus subset of chronic fatigue syndrome: improvement in left ventricular function.

Lerner AM, Beqaj SH, Deeter RG, Dworkin HJ, Zervos M, Chang CH, Fitzgerald JT, Goldstein J, O'Neill W.

Drugs Today (Barc). 2002 Aug;38(8):549-61. Review.

PMID:
12582420
6.
8.
9.

Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset.

Lerner AM, Ariza ME, Williams M, Jason L, Beqaj S, Fitzgerald JT, Lemeshow S, Glaser R.

PLoS One. 2012;7(11):e47891. doi: 10.1371/journal.pone.0047891. Epub 2012 Nov 14.

10.

Prevalence of abnormal cardiac wall motion in the cardiomyopathy associated with incomplete multiplication of Epstein-barr Virus and/or cytomegalovirus in patients with chronic fatigue syndrome.

Lerner AM, Dworkin HJ, Sayyed T, Chang CH, Fitzgerald JT, Beqaj S, Deeter RG, Goldstein J, Gottipolu P, O'Neill W.

In Vivo. 2004 Jul-Aug;18(4):417-24.

11.

Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome.

Cameron B, Flamand L, Juwana H, Middeldorp J, Naing Z, Rawlinson W, Ablashi D, Lloyd A.

J Med Virol. 2010 Oct;82(10):1684-8. doi: 10.1002/jmv.21873.

PMID:
20827765
12.

Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein-Barr virus IgG antibody titers.

Watt T, Oberfoell S, Balise R, Lunn MR, Kar AK, Merrihew L, Bhangoo MS, Montoya JG.

J Med Virol. 2012 Dec;84(12):1967-74. doi: 10.1002/jmv.23411.

13.

The lifestyle of patients with chronic fatigue syndrome and the effect on fatigue and functional impairments.

Goedendorp MM, Knoop H, Schippers GM, Bleijenberg G.

J Hum Nutr Diet. 2009 Jun;22(3):226-31. doi: 10.1111/j.1365-277X.2008.00933.x. Epub 2009 Feb 17.

PMID:
19226353
14.

Seroepidemiology of chronic fatigue syndrome: a case-control study.

Mawle AC, Nisenbaum R, Dobbins JG, Gary HE Jr, Stewart JA, Reyes M, Steele L, Schmid DS, Reeves WC.

Clin Infect Dis. 1995 Dec;21(6):1386-9.

PMID:
8749620
15.

Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome.

Montoya JG, Kogelnik AM, Bhangoo M, Lunn MR, Flamand L, Merrihew LE, Watt T, Kubo JT, Paik J, Desai M.

J Med Virol. 2013 Dec;85(12):2101-9. doi: 10.1002/jmv.23713. Epub 2013 Aug 19.

16.

Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome.

Loebel M, Strohschein K, Giannini C, Koelsch U, Bauer S, Doebis C, Thomas S, Unterwalder N, von Baehr V, Reinke P, Knops M, Hanitsch LG, Meisel C, Volk HD, Scheibenbogen C.

PLoS One. 2014 Jan 15;9(1):e85387. doi: 10.1371/journal.pone.0085387. eCollection 2014.

17.
18.

Case control study of chronic fatigue in pediatric patients.

Carter BD, Edwards JF, Kronenberger WG, Michalczyk L, Marshall GS.

Pediatrics. 1995 Feb;95(2):179-86.

PMID:
7838632
19.

Antibodies to Epstein-Barr virus in patients with chronic fatigue.

Matthews DA, Lane TJ, Manu P.

South Med J. 1991 Jul;84(7):832-40. Review.

PMID:
1648795
20.

[Symptoms, signs and laboratory findings in patients with chronic fatigue syndrome].

Kuratsune H, Yamaguti K, Hattori H, Tazawa H, Takahashi M, Yamanishi K, Kitani T.

Nihon Rinsho. 1992 Nov;50(11):2665-72. Review. Japanese.

PMID:
1337562

Supplemental Content

Support Center